HyperlynX: A Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and Radiotherapy in Patients with Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Saba, N. F. [1 ]
Sukari, A. [2 ]
Forget, F. [3 ]
Popovtzer, A. [4 ]
Perez, J. Rubio [5 ]
Park, J. H. [6 ]
Yang, M. H. [7 ]
Sato, M. [8 ,9 ]
Kuipers, M. [10 ]
Ito, R. [8 ,9 ]
Salmioll, S.
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[2] Karmanos Canc Inst, Detroit, MI USA
[3] Ctr Hosp Ardenne, Libramont, Belgium
[4] Hadassah Med Ctr Ein Kerem, Jerusalem, Israel
[5] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain
[6] Konkuk Univ, Med Ctr, Seoul, South Korea
[7] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Ctr Immunooncol, Taipei, Taiwan
[8] Merck Biopharma Co Ltd, Merck KGaA, Darmstadt, Germany
[9] Merck Biopharma Co Ltd, Merck KGaA, Tokyo, Japan
[10] Merck KGaA, Healthcare Business, Darmstadt, Germany
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页码：E21 / E21
页数：1
相关论文
共 50 条
  • [1] Weekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma
    Sautois, Brieuc
    Schroeder, Helene
    Martin, Marie
    Piret, Pascal
    Demez, Pierre
    Bouchain, Olivier
    Mutijima, Eugene
    Moreau, Pierre
    JOURNAL OF BUON, 2016, 21 (04): : 979 - 988
  • [2] Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma
    Uchinami, Yusuke
    Yasuda, Koichi
    Kano, Satoshi
    Otsuka, Manami
    Hamada, Seijiro
    Suzuki, Takayoshi
    Tsushima, Nayuta
    Takahashi, Shuhei
    Fujita, Yoshihiro
    Miyazaki, Tomohiko
    Higaki, Hajime
    Taguchi, Jun
    Shimizu, Yasushi
    Sakashita, Tomohiro
    Homma, Akihiro
    Aoyama, Hidefumi
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [3] Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma
    Yusuke Uchinami
    Koichi Yasuda
    Satoshi Kano
    Manami Otsuka
    Seijiro Hamada
    Takayoshi Suzuki
    Nayuta Tsushima
    Shuhei Takahashi
    Yoshihiro Fujita
    Tomohiko Miyazaki
    Hajime Higaki
    Jun Taguchi
    Yasushi Shimizu
    Tomohiro Sakashita
    Akihiro Homma
    Hidefumi Aoyama
    Discover Oncology, 14
  • [4] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck - A multicentre, retrospective analysis
    Rothschild, S., I
    Helfenstein, S.
    Riesterer, O.
    Meier, U. R.
    Papachristofilou, A.
    Kasenda, B.
    Pless, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 248 - 248
  • [5] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck: A multicentre, retrospective analysis
    Rothschild, S. I.
    Helfenstein, S.
    Riesterer, O.
    Meier, U. R.
    Papachristofilou, A.
    Kasenda, B.
    Pless, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Herchenhorn, Daniel
    Dias, Fernando L.
    Viegas, Celia M. P.
    Federico, Miriam H.
    Araujo, Carlos Manoel M.
    Small, Isabelle
    Bezerra, Marcos
    Fontao, Karina
    Knust, Renata E.
    Ferreira, Carlos G.
    Martins, Renato G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 696 - 702
  • [7] A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
    Yang, Eddy S.
    Deutsch, Eric
    Mehmet, Altan
    Fayette, Jerome
    Tao, Yungan
    Nabell, Lisle
    Spencer, Sharon A.
    Wang, Xuejing A.
    Spoljoric, Elizabeth A.
    Zhang, Wei
    Hynes, Scott M.
    Decker, Rodney L.
    Lin, Aimee K. Bence
    William, William N., Jr.
    RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 203 - 209
  • [8] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [9] Phase II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Herchenhorn, D.
    Dias, F. L.
    Pineda, R. M.
    Fonseca, A. J.
    Bezerra, M.
    Ferreira, C. G.
    Knust, R. E.
    Fontao, K.
    Martins, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck
    Planting, AST
    deMulder, PHM
    deGraeff, A
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 61 - 65
12345